OUI Inc., the Japanese Startup of a Smartphone-based Ophthalmic Diagnostic Medical Device, Wins First Prize at AEA2022 Innovation Awards – StreetInsider.com

FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2022
SocialTech Japan Wins First Prize in Social Business Session
CHIBA, Japan–(BUSINESS WIRE)– The Asian Entrepreneurship Award 2022 event (AEA2022) was held fully online from Wednesday, October 26th to Thursday, October 27th with the participation of 24 tech startups selected from Asian countries and regions. Among the competing participants, Japan’s OUI Inc., which develops the Smart Eye Camera (SEC), a smartphone-based medical device that enables ophthalmic diagnosis anytime, anywhere, and by anyone, was chosen as the winner.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221031005324/en/
AEA2022 First Prize Winner, OUI Inc. (Graphic: Business Wire)
AEA is a global innovation award for emerging Asian entrepreneurs and startups that are utilizing advanced technology to offer solutions to social issues. The AEA2022 brought together 24 selected startups from across Asia providing solutions in the three areas of healthcare, work & lifestyle reform, and sustainability, all of which are global key issues going forward.
Each company was selected on the basis of a wide range of criteria, including innovativeness, the social impact of their products and services, their commercial viability, the potential for collaboration with Japanese companies, the opportunity for business expansion in Japan, and OUI Inc. (Japan) was chosen as the winner.
This year, the Social Business Session in which participants competitively share business ideas for solving social problems was also held at the same time. Among the four participants of the session, SocialTech Japan (Japan), a provider of affordable medical services for achieving universal health coverage, won first prize.
AEA2022 Winners
OUI Inc. (Japan)
Smart Eye Camera (SEC), a smartphone-based medical device that enables ophthalmic diagnosis anytime, anywhere, and by anyone
Nervotec (Singapore)
Remote health management mobile platform for contactless measurement and analysis of physiological biomarkers using video analysis technology
[3rd place]
Liquium (New Zealand)
Clean ammonia production technology for fuels using a new catalyst that reduces capital and operating costs for industrial plants
[Special Award-AEA Social Business Award]
SocialTech Japan (Japan)
Affordable health services for universal health coverage
[Special Award-Fujitsu Accelerator Award]
Nervotec (Singapore)
[Special Award-IP Bridge Award]
OUI Inc. (Japan)
[Special Award-The Japan Academic Society for Ventures and Entrepreneurs Award]
Liquium (New Zealand)
[Special Award-Life Science Award]
OUI Inc. (Japan)
[Special Award-Microsoft Award]
ARAV Inc. (Japan)
A real-time remote control system that can be retrofitted to existing construction equipment and connected via the Internet
[Special Award-Audience Award]
Nervotec (Singapore)
For a list of startup entrants and their businesses, visit https://aea.events/e/startup-entrants/
About AEA2022
Official website: https://aea.events/e/ (English) / https://aea.events/j/ (Japanese)
Host: Asian Entrepreneurship Award steering committee
Division of University Corporate Relations – The University of Tokyo https://www.ducr.u-tokyo.ac.jp/en/
Mitsui Fudosan Co., Ltd. (Kashiwa-no-ha Smart City) https://www.kashiwanoha-smartcity.com/en/
TX Entrepreneur Partners General Incorporated Association (TEP) https://www.tepweb.jp/english/
The Japan Academic Society for Ventures and Entrepreneurs (JASVE) https://www.venture-ac.ne.jp/en/
Japan External Trade Organization (JETRO) https://www.jetro.go.jp/en/

View source version on businesswire.com: https://www.businesswire.com/news/home/20221031005324/en/
[General Enquiries] AEA2022 Steering Committee/Secretariat email:[email protected]
[Press] email:[email protected]
Source: Asian Entrepreneurship Award Steering Committee
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds – and more!


Leave a Reply

Your email address will not be published.